COBI Financials 07/16/2014 15:39:59
Compass Biotechnologies Inc.
Period Ending Jan 31, 2012 Jan 31, 2011 Jan 31, 2010
Total Revenue - - -
Cost of Revenue - - -
Gross Profit - - -
Operating Expenses
Research and Development 79 105 87
Sales, General and Admin. 756 1,235 318
Non-Recurring Items - 71 -
Other 61 78 1
Operating Income (896) (1,489) (406)
Income From Continuing Operations
Add'l Income/Expense Items 20 - 65
Earnings Before Interest and Tax (882) (1,489) (336)
Interest Expense - - -
Earnings Before Tax (882) (1,489) (336)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (876) (1,489) (341)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (876) (1,489) (341)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (876) (1,489) (341)